Articles tagged with “IV ketamine”
NRx Pharmaceuticals signals FDA review progress on its preservative-free ketamine application. What this means for patients and clinicians in 2026.
How are IV ketamine infusions dosed for treatment-resistant depression? Review of 0.5 mg/kg standard, session structure, monitoring, and evidence base.
Send corrections, provider questions, or advertising inquiries.
